IDiyas

For the Inventor, By the Inventor

Wortel, Belgium

Marcel Frans Leopold De Bruyn

USPTO Granted Patents = 14


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Hoogstraten, BE (2005 - 2008)
  • Beerse, BE (2016)
  • Wortel, BE (2002 - 2017)

Company Filing History:

goldMedal14 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 2002-2017

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 9751860 - Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists (2017-09-05),
2. 9468640 - Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists (2016-10-18),
3. 8940743 - Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists (2015-01-27),
4. 8440701 - Trisubstituted 1,2,4 triazoles (2013-05-14),
5. 8143419 - Trisubstituted 1,2,4-triazoles (2012-03-27),
6. 7423048 - Compounds for treating fundic disaccomodation (2008-09-09),
7. 7358239 - Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives (2008-04-15),
8. 7273862 - Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives (2007-09-25),
9. 7081453 - Compounds for treating impaired fundic relaxation (2006-07-25),
10. 6900222 - Pyrrolidinyl, piperdinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives (2005-05-31),
11. 6864273 - Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives (2005-03-08),
12. 6852714 - (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties (2005-02-08),
13. 6747045 - (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties (2004-06-08),
14. 6495547 - (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties (2002-12-17),

Title: Marcel Frans Leopold De Bruyn: A Trailblazer in Innovation

Introduction:

Marcel Frans Leopold De Bruyn, hailing from Wortel, Belgium, is a brilliant inventor whose contributions to the world of innovation are simply remarkable. His unwavering inventive spirit combined with a strong determination to make a difference sets him apart as a pioneering figure in the realm of inventors.

Latest Patents:

De Bruyn's latest patents include groundbreaking inventions in the pharmaceutical field. His patented compounds, "Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists," are designed to revolutionize the treatment of psychosis, including schizophrenia and related disorders. These compounds offer a promising avenue for patients in need of effective treatment.

Career Highlights:

With an impressive portfolio of 14 patents to his name, De Bruyn has established himself as a leader in the field of pharmaceutical innovation. His work at Janssen Pharmaceutica Nv showcases his exceptional talent and dedication to advancing medical science through inventive solutions.

Collaborations:

Throughout his career, De Bruyn has collaborated with esteemed colleagues such as Kristof Van Emelen and Piet Tom Bert Paul Wigerinck. Working alongside these talented individuals has allowed him to further push the boundaries of innovation in the pharmaceutical sector.

Conclusion:

In conclusion, Marcel Frans Leopold De Bruyn's impact on the world of innovation is truly profound. His groundbreaking inventions and groundbreaking approach to problem-solving continue to inspire future generations of inventors. De Bruyn's legacy as a trailblazer in the field of pharmaceutical innovation is set to endure for years to come, shaping the landscape of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…